Dr Holgate stated (when responding to the Speywood issue): "As I am sure you are aware one of the cornerstones of our philosophy for the licensing of 'biological' products is to have detailed knowledge of and control over early stages of manufacture and in-process control - this including source material."
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Regulation of Commercial Factor Concentrates